eliprodil has been researched along with pd 174494 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bigge, CF; Boxer, PA; Cai, SX; Coughenour, LL; Espitia, SA; Hawkinson, JE; Keana, JF; Konkoy, CS; Rock, DM; Tran, M; Weber, E; Whittemore, ER; Wise, LD; Woodward, RM; Zhou, ZL | 1 |
1 other study(ies) available for eliprodil and pd 174494
Article | Year |
---|---|
4-Hydroxy-1-[2-(4-hydroxyphenoxy)ethyl]-4-(4-methylbenzyl)piperidine: a novel, potent, and selective NR1/2B NMDA receptor antagonist.
Topics: Animals; Cerebral Cortex; Excitatory Amino Acid Antagonists; Mice; Neurons; Oocytes; Patch-Clamp Techniques; Piperidines; Potassium Channel Blockers; Potassium Channels; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; Receptors, N-Methyl-D-Aspartate; Structure-Activity Relationship; Superior Cervical Ganglion; Xenopus laevis | 1999 |